| Literature DB >> 12970181 |
María José Lafuente1, Pilar Martin, Isabel Garcia-Cao, María Teresa Diaz-Meco, Manuel Serrano, Jorge Moscat.
Abstract
The genetic inactivation of the atypical protein kinase C (aPKC) inhibitor, Par-4, gives rise to increased NF-kappaB activation and decreased stimulation of JNK in embryo fibroblasts. Here we have characterized the immunological phenotype of the Par-4(-/-) mice and found that the loss of this gene leads to an increased proliferative response of peripheral T cells when challenged through the TCR. This is accompanied by a higher increase in cell cycle entry and inhibition of apoptosis, with enhanced IL-2 secretion but normal CD25 synthesis. Interestingly, the TCR-triggered activation of NF-kappaB was augmented and that of JNK was severely abrogated. Consistent with previous data from knock outs of different JNKs, NFATc1 activation and IL-4 secretion were augmented in the Par-4-deficient CD4+ T cells, suggesting that the loss of Par-4 drives T-cell differentiation towards a Th2 response. This is compelling evidence that Par-4 is a novel modulator of the immune response through its ability to impact aPKC activity, which translates into lower JNK signaling.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12970181 PMCID: PMC212727 DOI: 10.1093/emboj/cdg460
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598